𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Malignant diseases among patients with multiple sclerosis

✍ Scribed by Jorma Palo; Jules Duchesne; Juhani Wikström

Book ID
104717898
Publisher
Springer
Year
1977
Tongue
English
Weight
317 KB
Volume
216
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

✦ Synopsis

The frequency of malignant diseases among 1866 living and 340 deceased multiple sclerosis (MS) patients was investigated in Finland. The study revealed a low prevalence (0.64%) and mortality (0.07%) rate of cancer among MS patients. The difference between MS patients and general population was significant. The highest rate was found in the group from 40 to 49 years while in the general population the rate of cancer among MS patients tended to fall after the age of 50. The possible role of selenium, one of the antioxidants in the pathogenesis of MS and cancer, is discussed because recent data have shown a very high negative correlation between selenium and cancer death rates.

📜 SIMILAR VOLUMES

Variations in centromeric heterochromati
Variations in centromeric heterochromatin among patients with pre-malignant and malignant oral diseases
✍ Bhavana J. Dave; Amit H. Trivedi; Siddharth G. Adhvaryu 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 480 KB

Polymorphism of heterochromatic regions of chromosomes I, 9 and I6 was studied in 60 oral cancer patients, in 40 patients with oral submucous fibrosis (OSMF) and in 60 normal healthy subjects. The size heteromorphism was significantly greater (p < 0.001) in chromosome I of the patients. Localization

Cancer risk among patients with multiple
Cancer risk among patients with multiple sclerosis and their parents
✍ Bahmanyar, S.; Montgomery, S. M.; Hillert, J.; Ekbom, A.; Olsson, T. 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 305 KB

Background: We investigated cancer risk among patients with multiple sclerosis (MS) and whether variation by age at MS diagnosis helps to elucidate mechanisms underlying the previously reported reduced cancer risk. We also studied cancer risk among parents to ascertain if MS susceptibility genes may